Sutent Capsule
Product Images NDC 0069-0770

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sutent (NDC 0069-0770). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sutent 01)

FDA Label Image

Figure 1 (Sutent 02)

This is a comparison of the median weeks of SUTENT versus placebo conducted on 207 and 105 individuals respectively. The results show a significant difference in efficacy, with SUTENT having a median of 27.3 weeks while the placebo only had 6.4 weeks. The Hazard R is 3 with a 95% confidence interval between 0.23 and 0.47, indicating a strong effect size.*

FDA Label Image

Figure 2 (Sutent 03)

This text appears to be a table showing the Progression Free Survival Probability of two treatments SUTENT and FlNa. The median progression-free survival probability with SUTENT treatment is 47.3 weeks whereas with FlNa treatment it is 22.0 weeks. The table also includes some numerical values in the form of hazards ratio and probability, and the number of patients in each group.*

FDA Label Image

Figure 3 (Sutent 04)

This appears to be a chart showing the results of a clinical trial comparing SUTENT (N-309) to placebo (N-306) over a period of up to 6.8 years. The chart shows the number of subjects at risk over time and includes a hazard ratio and confidence interval.*

FDA Label Image

Figure 4 (Sutent 05)

This text provides information on the progression-free survival probability of SUTENT compared to a placebo. The data shows that SUTENT has a higher survival probability percentage than the placebo group, with a median of 10.2 months compared to 5 months. The graph also displays the time in months on the x-axis and the survival probability on the y-axis.*

FDA Label Image

Pfizer Logo (Sutent 06)

This text is a distribution information for Pfizer Labs, which is a division of Pfizer Inc located in NY, NY 10017. It suggests that Pfizer Inc is involved in the pharmaceutical industry and distributes products through Pfizer Labs.*

FDA Label Image

Pfizer Logo (Sutent 07)

"Distributed by Pfizer Labs, Division of Pfizer Inc, NY, NY 10017."*

FDA Label Image

Principal Display Panel (12.5 mg Capsule Bottle Label)

Store at 20-25°C (68-77°F). Always dispense with medication guide. NDC 0069-0550-38. Pfizer's Sutent contains sunitinib malate in capsules. Made in Singapore, each bottle has 28 capsules and is for prescription use only.*

FDA Label Image

Principal Display Panel (25 mg Capsule Bottle Label)

'Store at 20°C to 25°C (68°F to 77°F). ALWAYS DISPENSE WITH MEDICATON GUIDE. Sutent (sunitinib malate) e Capsules. NDC 0069-0770-38. 28 Capsules Rxonly. PRINTED ON LINE/ STAMPATO IN LINEA.'*

FDA Label Image

Principal Display Panel (50 mg Capsule Bottle Label)

FDA Label Image

Principal Display Panel (37.5 mg Capsule Bottle Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.